Mesoblast (MESO) Total Current Liabilities (2015 - 2025)

Mesoblast (MESO) has reported Total Current Liabilities for 11 consecutive years, with $128.1 million the latest figure, recorded in Q4 2025.

• Quarterly Total Current Liabilities rose 76.04% year-over-year to $128.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $128.1 million (up 76.04% YoY) and the FY2025 annual result came in at $102.6 million, up 40.12% from the prior year.
• Total Current Liabilities climbed to $128.1 million in Q4 2025 per MESO's latest filing, from $102.6 million in the prior quarter.
• Over the last five years, Total Current Liabilities for MESO reached as high as $128.1 million in Q4 2025 and fell as low as $31.4 million in Q4 2023.
• A 5-year average of $70.3 million and a median of $58.0 million in 2021 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities plunged 47.47% — and 2024, when it soared 131.93%.
• Year by year, Total Current Liabilities stood at $58.0 million in 2021, then retreated by 5.83% to $54.6 million in 2022, then sank by 42.53% to $31.4 million in 2023, then surged by 131.93% to $72.8 million in 2024, then surged by 76.04% to $128.1 million in 2025.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $128.1 million, $102.6 million, and $72.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.